Contact this trialFirst, we need to learn more about you.
Monoclonal Antibodies
Copper Cu 64-DOTA-Trastuzumab PET for HER2 Positive Breast Cancer
Recruiting1 award12 criteria
Duarte, California
This trial will study how well copper Cu 64-DOTA-trastuzumab PET works in predicting response to ado-trastuzumab emtansine in patients with HER2 positive breast cancer.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.